Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NF𝜿B and Akt/mTOR Signaling Pathways

Figure 1

Growth inhibition of human cervical cancer cell lines HeLa treated with genistein, cisplatin, and the combination treatments were evaluated by the MTT assay. HeLa cells were treated with genistein (25 μM), cisplatin (250 nM), and the combination treatment. *𝑃<0.05; **𝑃<0.01.